 |
|
Aging and the Occurrence of Dementia
Findings From a Population-Based Cohort With a Large Sample of Nonagenarians
Eva von Strauss, MSc;
Matti Viitanen, PhD;
Diana De Ronchi, MD;
Bengt Winblad, PhD;
Laura Fratiglioni, PhD
Arch Neurol. 1999;56:587-592.
ABSTRACT
| |
Context In spite of numerous studies on the occurrence of dementia, many questions remain, such as the relation between age, aging, and dementing disorders. This question is relevant both for understanding the pathogenetic mechanism of the dementias and for the public health prospective because of the increasing number of 85-year-old or older persons in our population.
Objective To estimate the occurrence of dementia in the very old, including nonagenarians, in relation to age, gender, and different dementia types.
Design An epidemiological survey where all participants were clinically examined by physicians, assessed by psychologists, and interviewed by nurses. The Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) criteria for dementia were followed. A category of "questionable dementia" was added when all criteria were not fulfilled. A double diagnostic procedure was used for all subjects.
Setting Community-based population, including all inhabitants of 2 areas in central Stockholm, Sweden (N=1848).
Participants Of the 1848 subjects in the study population, 168 (9.1%) had died and 56 (3%) moved before examination. Of the remaining subjects, 1424 (87.7%) were examined, and the refusal rate was 12.3%.
Main Outcome Measures Age- and gender-specific prevalence figures, and gender- and education-adjusted odds ratios were used.
Results At the end of the diagnostic procedure, 358 clinically definite cases of dementia and 101 questionable cases of dementia were identified. Alzheimer disease (AD) contributed to 76.5%, and vascular dementia (VaD) to 17.9%. The prevalence of dementia increases from 13% in the 77- to 84-year-old subjects to 48% among persons 95 years and older (from 18% to 61% when questionable cases were included). The odds ratio for subjects 90 to 94 years and 95 years and older in comparison with 77- to 84-year-old subjects was 3.7 (95% confidence interval [CI], 2.7-5.1) and 6.5 (95% CI, 3.9-10.8) for dementia, 4.8 (95% CI, 3.3-7.0) and 8.0 (95% CI, 4.6-14.0) for persons with AD, 2.3 (95% CI, 1.3-4.2) and 4.6 (95% CI, 1.9-11.2) for VaD, respectively.
Conclusions Dementia prevalence continues to increase even in the most advanced ages. This increase is especially evident among women and is more clear for AD. We believe that our prevalence data reflect the differential distribution of dementia risk.
INTRODUCTION
IN RECENT years, several studies have addressed the issue of whether dementia is an "age- or aging-related disorder."1-3 In spite of numerous prevalence4-13 and incidence14-22 studies, it is still unclear if the exponential increase in dementia frequency with age continues, even in the advanced ages, as an inevitable feature of aging,9-10,13 or if the occurrence reaches a plateau in people 85 years and older.2-3
Moreover, we still do not know if dementia occurs with a different age distribution in men and women, as suggested by Fratiglioni et al,22-23 or if the relation between dementia occurrence and age varies according to different dementia types. Some authors12, 24 suggested that vascular dementia (VaD) may be the major cause of dementia in the highest ages, whereas others25 reached an opposite conclusion in a review article on VaD, suggesting that this type of dementing disorder may be more frequent in the youngest-old ages.
This uncertainty derives mainly from the difficulty in studying samples that include enough subjects 90 years and older to allow reliable estimations of dementia frequency in the very old. In fact, only 3 prevalence studies included more than 200 persons 90 years and older.6, 9, 11
To shed more light on this topic, we examined the occurrence of dementia and different dementia types using data gathered from the second wave of the longitudinal study carried out in the Kungsholmen district in Stockholm, Sweden.26 During this phase, to attain a higher precision in estimating dementia occurrence among the oldest old, the study population had been enlarged by adding all the 90-year-old and older inhabitants of a contiguous area.
SUBJECTS AND METHODS
STUDY POPULATION
The study population consisted of 2 groups: (1) all the 77-year-old and older subjects living in the Kungsholmen area and (2) all persons 90 years and older registered in the contiguous area, St Göran, on January 1, 1992, whether living at home or in institutions. These are 2 homogeneous populations with the same age- and gender-distribution and similar health care system as in the Stockholm area. On average, the subjects had lived 49.6 years in the Kungsholmen area and 45.1 years in the St Göran area.
Each subject was sent a personal letter explaining the study and the importance of participation but clearly stating that it was voluntary and that at any time they could discontinue participation.27-28 The study has been approved by the ethics committee of the Karolinska Institute.
DATA COLLECTION
All participants were examined following a standardized protocol, including a social interview performed by nurses, a neuropsychological battery, and a clinical examination. The psychological battery included the Mini-Mental State Examination (MMSE),29 free recall and recognition of random words,30 and digit span.31 These tests were chosen as they had been proven to best discriminate between subjects with and without dementia in the first wave of our project.32 All subjects were examined by physicians who assessed the elderly person's general, neurologic, cognitive, and psychiatric status, as well as medication use. The clinical examination was similar to a normal geriatric examination usually performed in clinical practice but structured and defined with scoring criteria. Depression was assessed with the Comprehensive Psychopathological Rating Scale.33 Several cognitive functions were tested, such as semantic and episodic memory, language, abstract thinking, praxis, visuospatial ability, calculation, and gnosia.22
To differentiate among various types of dementia, laboratory tests were performed (albumin, glucose, ferritin, vitamin B12, and thyroid functions). As neuroimaging was not available in all cases, these data were not taken into account in the diagnosis. An informant interview was carried out in 92% of the cases—it covered clinical and family history, current health status, and changes in cognitive and memory functioning.
The clinical examination was completed in April 1993. The average time between the onset of the study and the examination was 8.0±5.2 months; 41% of the subjects were examined within 6 months and 80% in 12 months.
DEMENTIA AND DEMENTIA-TYPE DIAGNOSIS
The Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) diagnostic criteria,34 with some modifications,35 were used for the clinical diagnosis of dementia and different dementia types. The cases fulfilling the DSM-III-R criteria were denominated "clinically definite dementia," in contrast to a category of "questionable dementia," which was used when there was evident memory impairment and daily life was affected but dysfunction of a second cognitive ability was questionable.22
Special attention was given to the definition of "social and work activities." According to the DSM-III-R criteria, cognitive disturbances can be diagnosed as dementia only if they interfere with such activities. As work activities, we considered daily activities in the home (preparing food, shopping, managing light household tasks, balancing a checkbook, and handling money), hobbies, and leisure activities. Social activities were defined as relationship with relatives and friends. The subject and a close relative were asked specifically to judge if any changes from previous levels of performance had occurred and, if so, to describe when and how.
Differential diagnosis between Alzheimer disease (AD) and VaD was based only on clinical data, including information from a relative concerning clinical history. More specifically, for a diagnosis of AD, gradual onset and progressive deterioration of dementia were required and all other specific causes of dementia had to be excluded. The diagnosis of VaD was based on clinical features of dementia with abrupt onset and stepwise deterioration; a history of stroke and/or focal deficits were required. The Hachinski scale36 was also used to support the differential diagnosis between AD and VaD. All subjects with a clinical dementia syndrome characteristic of AD but with a history of stroke were classified in the diagnostic category of "mixed dementia." When it was impossible to define the dementia type, a category of "unspecified type of dementia" was used. The diagnostic process has already been described, and the same double diagnostic procedure was used for all subjects.22, 35 Information on the duration of the disease was obtained by asking the relative when the first dementia-related symptoms appeared. Dementia severity was measured according to the Washington University Clinical Dementia Rating Scale (CDR)37 and was done by 1 physician.
DATA ANALYSIS
The relationship between dementia occurrence and aging was explored separately for both clinically definite and questionable dementia by using the following measures:
- Age- and gender-specific prevalence figures were calculated using as the numerator all cases with a final diagnosis and, as the denominator, the number of inhabitants of the 2 areas on the prevalence day. Ninety-five percent confidence intervals (95% CIs) were computed based on the binomial distribution.38 For clinically definite dementia the same analysis was performed for AD and VaD.
- Gender- and education-adjusted odds ratios (ORs) due to increasing age were derived from logistic regression analyses.39 Categories of education used were "elementary/vocational" and "high school/university." Age was entered as a continuous variable in 2 models (1-year or 5-year increment). Another model treated age as an indicator variable, comparing 3 age groups (85-89, 90-94, and
 95 years) to the reference category (77-84 years). Similar analyses were repeated for AD and VaD separately.
RESULTS
Of the 1848 subjects in the study population, 9.1% died, 3% had moved from the area before examination, and 12.3% refused to participate. Thus, 1424 persons were clinically examined and of them 502 persons were more than 89 years old (Table 1). Forty-five percent of the men and 36% of the women had more than 7 years of schooling.
|
|
|
|
Table 1. Study Population, Dropouts by Causes, and Participants (Clinically Examined), Distribution by Age and Gender
|
|
|
Number and clinical characteristics of questionable and clinically definite dementia by type are reported in Table 2. The other dementias were 4 cases of dementia in subjects with Parkinson disease, 2 cases of other neurologic diseases, 6 cases of alcohol dementia, and 8 cases with unspecified dementia type. Only 9 subjects with clinically definite dementia had an MMSE score above 23. Mild cases accounted for 85.1% among questionable dementia cases, while moderate and severe forms accounted for 66.5% of all the clinically definite dementia cases. Mild dementias were more frequently reported among the youngest age groups, both among questionable and definite dementia cases (32.6% and 31.7% in the 77- to 84-year-old age group decreasing to 12.8% and 8.3% in the 95-year-old age group, P=.01 and P<.001, respectively). Alzheimer disease and VaD had similar percentages of severe forms of dementia, as well as mean MMSE scores.
|
|
|
|
Table 2. Number of Cases, Cognitive Impairment (MMSE Score), Disease Severity (CDR), and Appearance of First Symptoms (Years) of Dementia Cases Separately for Questionable and Clinically Definite Forms*
|
|
|
The age- and gender-specific prevalence per 100 population, and adjusted ORs for clinically definite dementias are presented in Table 3. The prevalence of clinically definite dementia increases with age even in the most advanced ages. This increase was more pronounced for women than for men. The crude ORs for all clinically definite dementias were 2.2 (95% CI, 1.6-3.1) for the 85- to 89-year-old group; 4.1 (95% CI, 3.0-5.6) for the 90- to 94-year-old group; and 7.3 (95% CI, 4.5-12.0) for the 95-year-old and older group, with age group 77 to 84 years as the reference level. When gender and education were introduced into the logistic regression model, the association with increasing age was still present (Table 3). Analyzing age as a continuous variable, the adjusted OR for the 1-year age increment was 1.1 (95% CI, 1.1-1.2) and for the 5-year increment, 1.9 (95% CI, 1.7-2.2).
|
|
|
|
Table 3. Number of Cases, Prevalence per 100 Population, and Adjusted Odds Ratios (aORs) for Clinically Definite Dementia of All Types, Distribution by Age and Gender*
|
|
|
The same pattern was found when questionable dementia cases were analyzed (Table 4). Due to the small number of cases, we could not stratify questionable dementia by gender. Moreover, we repeated the logistic regression analysis as described above, adding questionable dementia to clinically definite dementia in a first model and then adding questionable dementia to the group without dementia in a second model. The results did not change substantially.
|
|
|
|
Table 4. Number of Cases, Prevalence per 100 Population, and Adjusted Odds Ratios (aORs) for Questionable Dementia of All Types*
|
|
|
A stronger association between increasing age and dementia prevalence was observed for AD than for VaD (Figure 1). For AD, the prevalence was higher for women than men in each age stratum but especially among the oldest old.
|
|
|
|
Figure 1. Prevalence per 100 population and 95% confidence intervals (bars) of clinically definite Alzheimer disease (top) and definite vascular dementia (bottom). Distribution is by age and gender.
|
|
|
Crude ORs for AD were 3.0 (95% CI, 2.0-4.5) for the 85- to 89-year-old group, 5.3 (95% CI, 3.7-7.7) for the 90- to 94-year-old group, and 9.3 (95% CI, 5.4-16.1) for the 95-year-old and older group, when using age up to 84 years as the reference level. When gender and education were introduced into the model, the association with increasing age was still strong. An association between VaD and increasing age was also observed but only in the 90-year-old and older group. The same analyses were also performed separately for men and women, and the association with increasing age remained among women, whereas it was less clear among men (Figure 2).
|
|
|
|
Figure 2. Association of age and gender with Alzheimer disease and vascular dementia (adjusted for education) expressed as odds ratio and 95% confidence interval (bars). The group younger than 85 years is the reference level. The asterisk indicates no cases.
|
|
|
COMMENT
The present study is one of the few in which the relationship between the occurrence of dementia and different dementia types has been explored in a community population with a large sample of 90-year-old and older persons and in which all subjects were clinically examined. We found a steady increase of dementia prevalence with age, even in the most advanced ages. Our prevalence rates were 37% among persons aged 90 to 94 years and 48% among persons 95 years and older, and these figures would have increased up to 45% and 61%, respectively, if questionable dementia had been taken into account. This increase was evident among women but unclear among men. A similar pattern was found for AD; for VaD such a pattern was questionable. In all age strata, AD prevalence values were higher than VaD figures.
Several questions arise from these findings:
1. Is the positive association between dementia prevalence and age due to a continuous increase of dementia incidence with age? As prevalence is determined by both incidence and duration of the disease, differential survival at different ages among subjects with dementia has been suspected of affecting the age distribution of dementia prevalence.40 We attempted to verify the influence of the differential survival by estimating dementia incidence from prevalence figures and disease duration.41 Information on duration was gathered from a previous study42 in which incident dementia cases were followed up from diagnosis to death in a 5-year period. We found that for both men and women, the estimated incidence rates continued to increase with age even after 85 years. The frequency of questionable dementia also increased with age, and prevalence figures of questionable dementia are likely to be less affected by differential disease duration for different age groups. In conclusion, we believe that the increase of dementia prevalence is a result of an increased incidence of the disease with increasing age. Almost all the recent incidence studies, although limited by small numbers of nonagenarians, have shown a tendency toward an increase even after age 90 years.17-18,20, 22
Our findings are in complete agreement with other studies in Canada,9 Germany,10 and the United States,12 where similar prevalence figures and the same relationship with age were found. These findings support the hypothesis that dementia is an aging-related process, as suggested first by Jorm et al43 in 1987. Only 2 studies have reported data showing a plateau of dementia prevalence at the age of 85 years.2, 7 This disagreement could be due to methodological issues.44
2. Is the higher occurrence of dementia in old age due to differential misclassification in different age groups? Dementia diagnosis in population studies is always difficult,19, 35, 44-45 especially in old age.10 In the oldest-old people, it may be problematic to distinguish between early manifestations of dementia and changes associated with "normal aging." Although the DSM-III-R criteria were strictly followed in our study, some cases could not be classified with certainty, and, therefore, a category of questionable dementia was used.22 The interference with work and social life, as requested by the DSM-III-R, can sometimes be arduous to evaluate in old-old subjects. We tried to overcome these difficulties by asking the person and his or her family about any changes in daily activities, hobbies, and social activities. Moreover, each diagnosis was made twice, separately, by experienced clinicians (L.F. and M.V.) (geriatricians and neurologists). If a differential misclassification was present, it is more likely to have led to an underestimation of the prevalence among old subjects, as mild cases may be easily missed in this age group. In fact, the oldest-old persons are not expected to perform complicated activities as well as younger-old adults. Therefore, mild cognitive dysfunction does not interfere as much with social activities. A previous study8 pointed out that mild dementia decreased with age from 36% at 75 years to 13% at 85 years. In our study, we also found that the prevalence of mild dementia according to CDR criteria was lower in the oldest-old (8.3% vs 31.7%).
3. Is the differential age distribution of dementia prevalence between men and women true, or is it due to the small sample size of men? In our study, dementia prevalence continued to increase with age clearly among women, but not among men, and in all age strata women had higher prevalence than men. At the age of 95 years, the prevalence of dementia among women was 50% (62% if questionable dementia cases were included), whereas the corresponding figure for men was 30% (50% when questionable cases were included). Unfortunately, in spite of the enlargement of the nonagenarian stratum in the study population, there was still a limited number of male survivors when ages 85 years or older were considered. Thus, all our estimates for men, both the prevalence and the OR, lack precision. The increased prevalence of dementia among women reported in previous studies6, 12 has been attributed to their low educational attainment,13 but we found a higher prevalence among women even after adjustment for age and education.
4. May misdiagnosis lead to the differential age distribution in the occurrence of AD and VaD? Our results show that the continuing increase in dementia prevalence with increasing age is especially evident for AD, whereas it is more questionable for VaD. In the present study, the dementia diagnoses were based on clinical data only and not supported by neurologic investigations, such as computed tomography, magnetic resonance imaging, or autopsy. Thus, it is possible that VaD may have been underestimated but not necessarily in different ways in different age groups. Moreover, other studies have shown that both DSM-III and NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer's Disease and Related Disorders Association) criteria have good validity when the clinical diagnosis of dementia and AD are compared with findings on autopsy.46 Recently, a meta-analysis of validation studies concerning the use of the Hachinski scale reported an accuracy rate of 89%.47 We, therefore, believe that our diagnoses are sufficiently accurate to verify our hypothesis, although less accurate than the diagnoses made in a special clinical setting. Most studies in Western countries agree that the steep increase in dementia prevalence up to the age of 85 years is a result of the age distribution found in AD.5, 9, 11, 13, 48-49 Our data support these findings, even after the age of 90 years. In contrast, Skoog et al,24 who examined an 85-year-old population in Sweden, found that 47% of all dementia cases were affected by vascular or mixed dementia, suggesting that a vascular cause of dementia may be more common in old age than previously thought. The diagnostic procedure in the study by Skoog et al also used information from neuroimaging. Probably, in oldest-old ages, both vascular and degenerative mechanisms contribute to the development of dementia50-51 that can be attributed to one or the other subtype of dementia, depending on the diagnostic tools.
5. Could selection bias due to dropouts have determined some of our results? Refusal rate in our study was very low (12%). The subjects who refused had age- and gender distribution similar to that of the participants, so it is not likely that the refusals affected our results. However, it is not possible to say whether men at early stages of dementia are more likely to refuse a clinical examination than women in the same clinical situation. Of the study population, 168 (9%) died before being examined. This may have affected our results toward an underestimation of the dementia prevalence but not the differential distribution with age and gender. The information obtained from medical records and death certificates led to the identification of 1 case of dementia among the 39 men and 12 cases among the 129 women, leading to a higher percentage of dementia among dead women (9.4%) than among dead men (2.8%).
In conclusion, we found that dementia prevalence continues to increase with increasing age, even in the most advanced ages; the probability of having dementia increased by 10% each year, and 90% every 5 years. This increase is especially evident among women, and this pattern is more clear for AD than for VaD and is probably due to differential disease incidence. It is unlikely that misclassification and selection biases have contributed to these findings. Finally, the high prevalence of dementia and more severe cases among the oldest-old underscore the need for appropriate health care planning in our Western societies, as persons 85 years or older are the age group in the population who have and will experience the most dramatic increase.52
AUTHOR INFORMATION
Accepted for publication August 20, 1998.
This study was supported by grants from the Swedish Council for Social Research, the Swedish Medical Research Council, the Swedish Municipal Pension Institute, Torsten & Ragnar Söderbergs Foundation, Gun and Bertil Stohne Foundation, Loo and Hans Ostermans Foundation, SHMF-90 Foundation, and the Swedish Society for Medical Research, Stockholm; and the Alzheimer Foundation Sweden, Lund.
We thank all the members of the Kungsholmen Project Study Group for data collection and management, and Margaret Maytan, MD, for providing valuable comments.
Corresponding author: Eva von Strauss, MSc, Stockholm Gerontology Research Center, Box 6401, S-113 82 Stockholm, Sweden (e-mail: Eva.von.Strauss{at}neurotec.ki.se).
From the Stockholm Gerontology Research Center, Division of Geriatric Medicine, Neurotec, Karolinska Institute, Stockholm, Sweden (Ms von Strauss and Drs Viitanen, De Ronchi, Winblad, and Fratiglioni); and the Institute of Psychiatry, University of Bologna, Bologna, Italy (Dr De Ronchi).
REFERENCES
| |
1. Ritchie K, Kildea D, Robine J-M. The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data. Int J Epidemiol. 1992;21:763-769.
FREE FULL TEXT
2. Wernicke TF, Reischies FM. Prevalence of dementia in old age: clinical diagnoses in subjects aged 95 years and older. Neurology. 1994;44:250-253.
FREE FULL TEXT
3. Ritchie K, Kildea D. Is senile dementia "age-related" or "aging-related"? evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995;346:931-934.
FULL TEXT
|
ISI
| PUBMED
4. Rocca WA, Bonaiuto S, Lippi A, et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: a door-to-door survey in Appignano, Macerata province, Italy. Neurology. 1990;40:626-631.
FREE FULL TEXT
5. Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer's disease and other dementias in an elderly population: relationship with age, sex, and education. Neurology. 1991;41:1886-1892.
FREE FULL TEXT
6. Heeren TJ, Lagaay AM, Hijmans W, Rooymans HGM. Prevalence of dementia in the "oldest old" of a Dutch community. J Am Geriatr Soc. 1991;39:755-759.
ISI
| PUBMED
7. Engedal K, Haugen PK. The prevalence of dementia in a sample of elderly Norwegians. Int J Geriatr Psychiatry. 1993;8:565-570.
FULL TEXT
|
ISI
8. Juva K, Sulkava R, Erkinjuntti T, Valvanne J, Tilvis R. Prevalence of dementia in the city of Helsinki. Acta Neurol Scand. 1993;87:106-110.
ISI
| PUBMED
9. Ebly EM, Parhad IM, Hogan DB, Fung TS. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology. 1994;44:1593-1600.
FREE FULL TEXT
10. Fichter MM, Meller I, Schröppel H, Steinkirchner R. Dementia and cognitive impairment in the oldest old in the community: prevalence and comorbidity. Br J Psychiatry. 1995;166:621-629.
FREE FULL TEXT
11. Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education—the Rotterdam Study. BMJ. 1995;310:970-973.
FREE FULL TEXT
12. Graves AB, Larson EB, Edland SD, et al. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington State. Am J Epidemiol. 1996;144:760-771.
FREE FULL TEXT
13. Prencipe M, Casini AR, Ferretti C, Lattanzio MT, Fiorelli M, Culasso F. Prevalence of dementia in an elderly rural population: effects of age, sex and education. J Neurol Neurosurg Psychiatry. 1996;60:628-633.
FREE FULL TEXT
14. Copeland JRM, Davidsson IA, Dewey ME, et al. Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-years outcome in Liverpool. Br J Psychiatry. 1992;161:230-239.
FREE FULL TEXT
15. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993;43:515-519.
FREE FULL TEXT
16. Kokmen E, Beard CM, O'Brien PC, Offord KP, Kurland LT. Is the incidence of dementing illness changing? a 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology. 1993;43:1887-1892.
FREE FULL TEXT
17. Letenneur L, Commenges D, Dartigues JF, Barbeger-Gateau P. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol. 1994;23:1256-1261.
FREE FULL TEXT
18. Paykel ES, Brayne C, Huppert FA, et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry. 1994;51:325-332.
FREE FULL TEXT
19. Brayne C, Gill C, Huppert FA, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for Later Life. Br J Psychiatry. 1995;167:255-262.
FREE FULL TEXT
20. Gussekloo J, Heeren TJ, Izaks GJ, Ligthart GJ, Rooijmans HGM. A community based study of the incidence of dementia in subjects aged 85 years and over. J Neurol Neurosurg Psychiatry. 1995;59:507-510.
FREE FULL TEXT
21. Johansson B, Zarit SH. Prevalence and incidence of dementia in the oldest old: a longitudinal study of a population-based sample of 84-90-year-olds in Sweden. Int J Geriatr Psychiatry. 1995;10:359-366.
22. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48:132-138.
FREE FULL TEXT
23. Fratiglioni L, Viitanen M, von Strauss E, Winblad B. Late-onset Alzheimer's disease: incidence data from the Kungsholmen Project. In: Iqbal K, Winblad B, Wisniewski HM, eds. Alzheimer's Disease: Biology, Diagnosis and Therapeutics. New York, NY: John Wiley & Sons Ltd; 1997:49-53.
24. Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993;328:153-158.
FREE FULL TEXT
25. Hébert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995;14:240-257.
FULL TEXT
|
ISI
| PUBMED
26. Fratiglioni L, Viitanen M, Bäckman L, Sandman P-O, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology. 1992;11(suppl 1):29-36.
27. von Strauss E, Fratiglioni L, Jorm AF, Viitanen M, Winblad B. Attitudes and participation of the elderly in population surveys: data from a longitudinal study on aging and dementia in Stockholm. J Clin Epidemiol. 1998;51:181-187.
FULL TEXT
|
ISI
| PUBMED
28. Swedish Council for Research in the Humanities & Social Sciences (HSFR). Ethical Principles in Research. Stockholm: Swedish Council for Research in the Humanities & Social Sciences (HSFR); 1991.
29. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
FULL TEXT
|
ISI
| PUBMED
30. Molander B. Imagery, Visual and Tactual Dimensions of Imagery, and Meaningfulness: Swedish Norms for 854 Nouns. Umeå, Sweden: University of Umeå; 1984. Technical Report 178.
31. Weschler D. Manual for the Wechsler Adult Intelligence Scale. New York, NY: Psychological Corp; 1981.
32. Herlitz A, Hill RD, Fratiglioni L, Bäckman L. Episodic memory and visuospatial ability in detecting and staging dementia in a community-based sample of very old adults. J Gerontol. 1995;50:107-113.
ISI
33. Perris C, Eisemann M, von Knorring L, Perris H. Presentation of a subscale for the rating of depression and some additional items to the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand. 1984;70:261-274.
ISI
| PUBMED
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
35. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Winblad B. Clinical diagnosis of Alzheimer's disease and other dementias in a population survey: agreement and causes of disagreement in applying DSM-III-R criteria. Arch Neurol. 1992;49:927-932.
FREE FULL TEXT
36. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632-637.
FREE FULL TEXT
37. Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
FREE FULL TEXT
38. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford, England: Blackwell Science Ltd; 1987:115-120.
39. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
40. Drachman DA. If we live long enough, will we all be demented? Neurology. 1994;44:1563-1565.
FREE FULL TEXT
41. Freeman J, Hutchinson GB. Prevalence, incidence and duration. Am J Epidemiol. 1980;112:707-723.
FREE FULL TEXT
42. Agüero-Torres H. Natural History of Alzheimer's Disease and Other Dementias: Findings From a Population Survey. Stockholm, Sweden: Dept of Clinical Neuroscience and Family Medicine, Division of Geriatric Medicine, Karolinska Institute; 1998.
43. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76:465-479.
ISI
| PUBMED
44. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337:1667-1674.
FREE FULL TEXT
45. Morris M. Dementia and cognitive changes in Huntington's disease. Rev Adv Neurol. 1995;65:187-200.
46. Kukull WA, Larsson EB, Reifler BV, Lampe TH, Yerby MS, Hughes JP. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology. 1990;40:1364-1369.
FREE FULL TEXT
47. Moroney JT, Bagiella E, Desmond DW, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology. 1997;49:1096-1105.
FREE FULL TEXT
48. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA. 1989;262:2551-2556.
FREE FULL TEXT
49. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology. 1993;43:13-20.
FREE FULL TEXT
50. Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol. 1997;244:135-142.
FULL TEXT
|
ISI
| PUBMED
51. Fratiglioni L. Epidemiology. In: Winblad B, Wimo A, Karlsson G, eds. The Health Economics of Dementia. New York, NY: John Wiley & Sons Ltd; 1998:13-31.
52. Statistics Sweden (SCB). The Future Population of Sweden: Projection for the Years 1991-2025. Stockholm: Statistics Sweden; 1991.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(5):634-636.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
APOE {varepsilon}2 is associated with intact cognition but increased Alzheimer pathology in the oldest old
Berlau et al.
Neurology 2009;72:829-834.
ABSTRACT
| FULL TEXT
Gene expression changes in the course of normal brain aging are sexually dimorphic
Berchtold et al.
Proc. Natl. Acad. Sci. USA 2008;105:15605-15610.
ABSTRACT
| FULL TEXT
Role of the Neuropathology of Alzheimer Disease in Dementia in the Oldest-Old
Haroutunian et al.
Arch Neurol 2008;65:1211-1217.
ABSTRACT
| FULL TEXT
Prevalence of dementia after age 90: Results from The 90+ Study
Corrada et al.
Neurology 2008;71:337-343.
ABSTRACT
| FULL TEXT
Non-cardiovascular co-morbidity in elderly patients with heart failure outnumbers cardiovascular co-morbidity
van der Wel et al.
Eur J Heart Fail 2007;9:709-715.
ABSTRACT
| FULL TEXT
Health Trends in the Elderly Population: Getting Better and Getting Worse
Parker and Thorslund
Gerontologist 2007;47:150-158.
ABSTRACT
| FULL TEXT
Effect of a clinical stroke on the risk of dementia in a prospective cohort
Gamaldo et al.
Neurology 2006;67:1363-1369.
ABSTRACT
| FULL TEXT
Dementia-free survival among centenarians: an evidence-based review.
Calvert et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2006;61:951-956.
ABSTRACT
| FULL TEXT
Heart Disease and Dementia: A Population-based Study
Bursi et al.
Am J Epidemiol 2006;163:135-141.
ABSTRACT
| FULL TEXT
The prevalence of dementia in 95 year olds
Borjesson-Hanson et al.
Neurology 2004;63:2436-2438.
ABSTRACT
| FULL TEXT
Dementia and Depressive Symptoms as Predictors of Home Help Utilization Among the Oldest Old: Population-Based Study in an Urban Area of Sweden
Larsson et al.
J Aging Health 2004;16:641-668.
ABSTRACT
The Decreasing Prevalence of Reversible Dementias: An Updated Meta-analysis
Clarfield
Arch Intern Med 2003;163:2219-2229.
ABSTRACT
| FULL TEXT
Alzheimer Disease
Cummings and Cole
JAMA 2002;287:2335-2338.
FULL TEXT
Prevalence of dementia according to DSM--III--R and ICD--10: Results of the Leipzig Longitudinal Study of the Aged (LEILA75+) Part 1
RIEDEL-HELLER et al.
Br. J. Psychiatry 2001;179:250-254.
ABSTRACT
| FULL TEXT
Cognitive function in the oldest old: women perform better than men
van Exel et al.
J. Neurol. Neurosurg. Psychiatry 2001;71:29-32.
ABSTRACT
| FULL TEXT
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan
Tang et al.
Neurology 2001;56:49-56.
ABSTRACT
| FULL TEXT
Genetic risk of Alzheimer's disease: advising relatives
LIDDELL et al.
Br. J. Psychiatry 2001;178:7-11.
ABSTRACT
| FULL TEXT
A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease
Crawford et al.
Neurology 2000;55:763-768.
ABSTRACT
| FULL TEXT
|
